Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. Drug testing is done mainly for illegal drugs. Illegal drugs are non-prescribed drug which are banned by governments. These drugs are consumed for non-medicinal reasons which can affects mental and physical health of addicts.
Highlights
The global Drug Testing market was valued at US$ 2941.2 million in 2022 and is anticipated to reach US$ 3430.9 million by 2029, witnessing a CAGR of 2.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Drug Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Drug Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Drug Testing in Drug Testing Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Drug Testing include Express Diagnostics, Drgerwerk AG & Co., KGAA Alere, Quest Diagnostics, Laboratory Corporation of America MPD, Shimadzu, Roche Diagnostics, Quest Diagnostics and Thermo Fisher Scientific, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Testing.
The Drug Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Express Diagnostics
Drgerwerk AG & Co.
KGAA Alere
Quest Diagnostics
Laboratory Corporation of America MPD
Shimadzu
Roche Diagnostics
Quest Diagnostics
Thermo Fisher Scientific
Siemens Healthcare
Segment by Type
Breath Sample
Urine Sample
Hair Sample
Oral Fluid
Others
Segment by Application
Drug Testing Laboratories
Workplace and Schools
Criminal Justice System & Law Enforcement Agencies
Drug Treatment Centers
Hospitals
Pain Management Centers
Personal Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breath Sample
1.2.3 Urine Sample
1.2.4 Hair Sample
1.2.5 Oral Fluid
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Testing Laboratories
1.3.3 Workplace and Schools
1.3.4 Criminal Justice System & Law Enforcement Agencies
1.3.5 Drug Treatment Centers
1.3.6 Hospitals
1.3.7 Pain Management Centers
1.3.8 Personal Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Testing Market Perspective (2018-2029)
2.2 Drug Testing Growth Trends by Region
2.2.1 Global Drug Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Testing Historic Market Size by Region (2018-2023)
2.2.3 Drug Testing Forecasted Market Size by Region (2024-2029)
2.3 Drug Testing Market Dynamics
2.3.1 Drug Testing Industry Trends
2.3.2 Drug Testing Market Drivers
2.3.3 Drug Testing Market Challenges
2.3.4 Drug Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Testing Players by Revenue
3.1.1 Global Top Drug Testing Players by Revenue (2018-2023)
3.1.2 Global Drug Testing Revenue Market Share by Players (2018-2023)
3.2 Global Drug Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Testing Revenue
3.4 Global Drug Testing Market Concentration Ratio
3.4.1 Global Drug Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Testing Revenue in 2022
3.5 Drug Testing Key Players Head office and Area Served
3.6 Key Players Drug Testing Product Solution and Service
3.7 Date of Enter into Drug Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Testing Breakdown Data by Type
4.1 Global Drug Testing Historic Market Size by Type (2018-2023)
4.2 Global Drug Testing Forecasted Market Size by Type (2024-2029)
5 Drug Testing Breakdown Data by Application
5.1 Global Drug Testing Historic Market Size by Application (2018-2023)
5.2 Global Drug Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Testing Market Size (2018-2029)
6.2 North America Drug Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Testing Market Size by Country (2018-2023)
6.4 North America Drug Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Testing Market Size (2018-2029)
7.2 Europe Drug Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Testing Market Size by Country (2018-2023)
7.4 Europe Drug Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Testing Market Size (2018-2029)
8.2 Asia-Pacific Drug Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Testing Market Size (2018-2029)
9.2 Latin America Drug Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Testing Market Size by Country (2018-2023)
9.4 Latin America Drug Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Testing Market Size (2018-2029)
10.2 Middle East & Africa Drug Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Express Diagnostics
11.1.1 Express Diagnostics Company Detail
11.1.2 Express Diagnostics Business Overview
11.1.3 Express Diagnostics Drug Testing Introduction
11.1.4 Express Diagnostics Revenue in Drug Testing Business (2018-2023)
11.1.5 Express Diagnostics Recent Development
11.2 Drgerwerk AG & Co.
11.2.1 Drgerwerk AG & Co. Company Detail
11.2.2 Drgerwerk AG & Co. Business Overview
11.2.3 Drgerwerk AG & Co. Drug Testing Introduction
11.2.4 Drgerwerk AG & Co. Revenue in Drug Testing Business (2018-2023)
11.2.5 Drgerwerk AG & Co. Recent Development
11.3 KGAA Alere
11.3.1 KGAA Alere Company Detail
11.3.2 KGAA Alere Business Overview
11.3.3 KGAA Alere Drug Testing Introduction
11.3.4 KGAA Alere Revenue in Drug Testing Business (2018-2023)
11.3.5 KGAA Alere Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Drug Testing Introduction
11.4.4 Quest Diagnostics Revenue in Drug Testing Business (2018-2023)
11.4.5 Quest Diagnostics Recent Development
11.5 Laboratory Corporation of America MPD
11.5.1 Laboratory Corporation of America MPD Company Detail
11.5.2 Laboratory Corporation of America MPD Business Overview
11.5.3 Laboratory Corporation of America MPD Drug Testing Introduction
11.5.4 Laboratory Corporation of America MPD Revenue in Drug Testing Business (2018-2023)
11.5.5 Laboratory Corporation of America MPD Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Detail
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Drug Testing Introduction
11.6.4 Shimadzu Revenue in Drug Testing Business (2018-2023)
11.6.5 Shimadzu Recent Development
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Detail
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Drug Testing Introduction
11.7.4 Roche Diagnostics Revenue in Drug Testing Business (2018-2023)
11.7.5 Roche Diagnostics Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Drug Testing Introduction
11.8.4 Quest Diagnostics Revenue in Drug Testing Business (2018-2023)
11.8.5 Quest Diagnostics Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Drug Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Drug Testing Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Siemens Healthcare
11.10.1 Siemens Healthcare Company Detail
11.10.2 Siemens Healthcare Business Overview
11.10.3 Siemens Healthcare Drug Testing Introduction
11.10.4 Siemens Healthcare Revenue in Drug Testing Business (2018-2023)
11.10.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Express Diagnostics
Drgerwerk AG & Co.
KGAA Alere
Quest Diagnostics
Laboratory Corporation of America MPD
Shimadzu
Roche Diagnostics
Quest Diagnostics
Thermo Fisher Scientific
Siemens Healthcare
听
听
*If Applicable.